Genomatica
Genomatica builds bio-based BDO (1,4-butanediol) and nylon intermediates using engineered microbial fermentation from renewable feedstock (sugar).
New patent ·
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Founded
- 2007
- Latest Form D
- $119M, Aug 2021
- Total capital
- $173M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $172M
- 3 Form D · last Aug 2021
- 63 months since last filing
- Federal contracts
- $761K
- 2 awards · Defense, Health and Human S
- Rank in Biotech#204 of 4373
- Granted patents
- 19
- 21 pending · first 2025
- Rank in peer group#9 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$119M
- Federal contractHealth and Human S · Nichd - Chemicals.$12K
- Private capital raisedForm D · SEC · 2nd filing$6.8M
- Private capital raisedForm D · SEC · 1st filing$46.4M
- Federal contractDefense · Scientific Research Service$750K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
64months
from Genomatica’s first federal award to its first private round.
- First federal award · Apr 2007
- Defense · $750K
- First Form D · Aug 2012
- $46.4M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#9 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Anders Bendsen SpohrDirectorNamed in SEC Form D filings
- Carlos A. CabreraExecutive Officer, DirectorNamed in SEC Form D filings
- Christophe SchillingExecutive Officer, DirectorNamed in SEC Form D filings
- Craig A. BinettiDirectorNamed in SEC Form D filings
- David Bendsen MuldoonExecutive OfficerNamed in SEC Form D filings
- Eli A. CasdinDirectorNamed in SEC Form D filings
Show all 20 people
- Geoff H. DuykDirectorNamed in SEC Form D filings
- Jason A. KellyDirectorNamed in SEC Form D filings
- Jeff J.G. LievenseExecutive OfficerNamed in SEC Form D filings
- Josh H. GreenDirectorNamed in SEC Form D filings
- Just J.G. JanszDirectorNamed in SEC Form D filings
- Leighton J.G. ReadDirectorNamed in SEC Form D filings
- Mark J.G. BurkExecutive OfficerNamed in SEC Form D filings
- Michael J.G. KeaneExecutive OfficerNamed in SEC Form D filings
- Michael J.G. SavageDirectorNamed in SEC Form D filings
- Rasmus Bendsen von GottbergExecutive OfficerNamed in SEC Form D filings
- Thomas J.G. HuotDirectorNamed in SEC Form D filings
- Thomas Bendsen McDonaldExecutive OfficerNamed in SEC Form D filings
- Warren H. ClarkDirectorNamed in SEC Form D filings
- William H. BaumExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 19 granted of 40- New patentProduction Of Odd Chain Fatty Acid Derivatives In Recombinant Microbial CellsUSPTOUS 12,760,339
- New patentMicroorganisms And Methods For Producing (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATEUSPTOUS 12,760,338
- PendingEngineered Trans-enoyl Coa Reductase And Methods Of Making And UsingUSPTOApplication 19389696
Show all 40 patent records
- Production Of Odd Chain Fatty Acid Derivatives In Recombinant Microbial CellsOct 13, 2026 · US 12,760,339Granted
- Microorganisms And Methods For Producing (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATEOct 13, 2026 · US 12,760,338Granted
- Engineered Trans-enoyl Coa Reductase And Methods Of Making And UsingAug 20, 2026 · Application 19389696Pending
- Omega-Hydroxylase-Related Fusion Polypeptides With Improved PropertiesAug 4, 2026 · US 12,698,481Granted
- Microorganisms And Methods For Improving Product Yields On Methanol Using Acetyl-coa SynthesisJul 23, 2026 · Application 19429362Pending
- Enzymatic Biosynthesis Of LactonesJul 9, 2026 · Application 19562232Pending
- Microorganisms And Methods For Enhancing The Availability Of Reducing Equivalents In The Presence Of Methanol, And For Producing 1,4-BUTANEDIOL Related TheretoJun 30, 2026 · US 12,668,820Granted
- Production Of Fatty Acid DerivativesJun 23, 2026 · US 12,662,679Granted
- Production Of Non-Native Monounsaturated Fatty Acids In BacteriaJun 9, 2026 · US 12,649,937Granted
- Methods And Organisms With Increased Carbon Flux EfficienciesApr 16, 2026 · Application 19325355Pending
- Enzymatic Biosynthesis Of LactonesApr 7, 2026 · US 12,595,496Granted
- Methods Of Producing Omega-Hydroxylated Fatty Acid DerivativesApr 7, 2026 · US 12,595,495Granted
- Engineered Microorganisms And Methods For Improved Aldehyde Dehydrogenase ActivityMar 17, 2026 · US 12,577,594Granted
- Microorganisms And Methods For Increasing Co-factorsMar 17, 2026 · US 12,577,591Granted
- Multifunctional Fatty Acid Derivatives And Biosynthesis ThereofMar 5, 2026 · Application 19297245Pending
- Engineered Microorganisms With G3P ->3PG Enzyme And/or FRUCTOSE-1,6-BISPHOSPHATASE Including Those Having Synthetic Or Enhanced MethylotrophyFeb 5, 2026 · Application 19043192Pending
- Method Of Producing & Processing DiaminesJan 29, 2026 · Application 19353369Pending
- Methanol Dehydrogenase Fusion ProteinsJan 27, 2026 · US 12,534,710Granted
- Microorganisms And Methods For Improving Product Yields On Methanol Using Acetyl-coa SynthesisJan 20, 2026 · US 12,529,078Granted
- Production Of Non-Native Monounsaturated Fatty Acids In BacteriaJan 8, 2026 · Application 19008032Pending
- Downstream Processing Of Fatty Alcohol Compositions Produced By Recombinant Host CellsJan 6, 2026 · US 12,516,007Granted
- Flavin-dependent Oxidases Having Cannabinoid Synthase ActivityDec 25, 2025 · Application 18842644Pending
- Methods For Enhancing Microbial Production Of Specific Length Fatty Alcohols In The Presence Of MethanolDec 25, 2025 · Application 19207233Pending
- Method Of Producing & Processing Diamines To A Diamine Free Base Using A Carbonate Intermediate And An Engineered MicroorganismDec 23, 2025 · US 12,503,711Granted
- Aldehyde Dehydrogenase Variants And Methods Of Using SameDec 18, 2025 · Application 19252918Pending
- Aldehyde Dehydrogenase Variants And Methods Of UseDec 4, 2025 · Application 18702714Pending
- Microorganisms And Methods For Production Of 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL And Related CompoundsNov 27, 2025 · Application 19187905Pending
- Cannabinoid Synthase Variants And Methods For Their UseNov 25, 2025 · US 12,480,144Granted
- 1,3-BUTYLENE Glycol Compositions And Methods Of UseOct 23, 2025 · Application 18853360Pending
- Aldehyde Dehydrogenase Variants And Methods Of UseOct 23, 2025 · Application 18701533Pending
- Microorganisms And Methods For Enhancing The Availability Of Reducing Equivalents In The Presence Of Methanol, And For Producing 1,4-BUTANEDIOL Related TheretoOct 16, 2025 · Application 19096503Pending
- Methods And Organisms With Increased Carbon Flux EfficienciesOct 7, 2025 · US 12,435,346Granted
- Methods and Compositions for Making Amide CompoundsOct 2, 2025 · Application 18260225Pending
- Neutral Taste 1,3-BUTYLENE Glycol Products And Compositions ThereofSep 25, 2025 · Application 18853349Pending
- Flavin-dependent Oxidases Having Cannabinoid Synthase ActivitySep 18, 2025 · Application 18687169Pending
- Methods For Enhancing Microbial Production Of Specific Length Fatty Alcohols In The Presence Of MethanolAug 26, 2025 · US 12,398,396Granted
- Enzyme Variants With Improved Ester Synthase PropertiesAug 26, 2025 · US 12,398,383Granted
- 1,3-Fatty Diol Compounds And Derivatives ThereofJul 31, 2025 · Application 19184068Pending
- Aldehyde Dehydrogenase Variants And Methods Of Using SameJul 29, 2025 · US 12,371,673Granted
- Neutral Odor 1,3-BUTYLENE Glycol Compositions And Methods Of Use ThereofJul 10, 2025 · Application 18853340Pending
Related companies, and why
- Planet Biotechnology IncorporatedSimilar federal contract value in Biotech · $828K in contracts
- SUJANA BIOTECH, LLCSimilar federal contract value in Biotech · $783K in contracts
- JUMPCODE GENOMICSSimilar federal contract value in Biotech · $765K in contracts
- ATUX ISKAY GROUP LLCSimilar federal contract value in Biotech · $755K in contracts
- Rigel PharmaceuticalsSimilar federal contract value in Biotech · $750K in contracts
- GRYPHON BIO INCSimilar federal contract value in Biotech · $749K in contracts
Press
Again acquires industrial biotech veteran GenomaticaAcs.org
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .